ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,471 Cr | ₹2,113 Cr | ₹1,703 Cr | ₹1,437 Cr | ₹1,481 Cr |
What is the latest Total Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹3,471 Cr |
Mar2022 | ₹2,113 Cr |
Mar2021 | ₹1,703 Cr |
Mar2020 | ₹1,437 Cr |
Mar2019 | ₹1,481 Cr |
How is Total Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹3,471 Cr | 64.31 | |
Mar2022 | ₹2,113 Cr | 24.07 | |
Mar2021 | ₹1,703 Cr | 18.51 | |
Mar2020 | ₹1,437 Cr | -2.95 | |
Mar2019 | ₹1,481 Cr | - |
Compare Total Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹11,757.2 Cr | -3% | 1.6% | 41% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -3% |
1.6% |
41% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses